NCT06924606 2026-02-06Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and ImmunotherapyShanghai Junshi Bioscience Co., Ltd.Phase 2 Recruiting66 enrolled